347 related articles for article (PubMed ID: 25851852)
1. The association of elevated trough serum vancomycin concentrations with obesity.
Richardson J; Scheetz M; O'Donnell EP
J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
Morrill HJ; Caffrey AR; Noh E; LaPlante KL
Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
[TBL] [Abstract][Full Text] [Related]
3. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
Hong J; Krop LC; Johns T; Pai MP
Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
6. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
7. The impact of vancomycin trough concentrations on outcomes in non-deep seated infections: a retrospective cohort study.
Wan M; Walker SAN; Martin E; Elligsen M; Palmay L; Leis JA
BMC Pharmacol Toxicol; 2018 Jul; 19(1):47. PubMed ID: 30064515
[TBL] [Abstract][Full Text] [Related]
8. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
[TBL] [Abstract][Full Text] [Related]
9. Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients.
Truong J; Smith SR; Veillette JJ; Forland SC
J Clin Pharmacol; 2018 Sep; 58(9):1123-1130. PubMed ID: 29957824
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of a vancomycin loading dose in children.
Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
[TBL] [Abstract][Full Text] [Related]
11. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
Denetclaw TH; Dowling TC; Steinke D
Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.
Morbitzer KA; Jordan JD; Sullivan KA; Durr EA; Olm-Shipman CM; Rhoney DH
Neurocrit Care; 2016 Oct; 25(2):250-7. PubMed ID: 26942732
[TBL] [Abstract][Full Text] [Related]
13. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
Ploessl C; White C; Manasco K
Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
[TBL] [Abstract][Full Text] [Related]
14. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
Reilly AM; Ding MX; Rower JE; Kiser TH
J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
[TBL] [Abstract][Full Text] [Related]
15. [Monitoring of vancomycin in pediatrics].
Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
[TBL] [Abstract][Full Text] [Related]
16. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin trough concentrations in overweight or obese pediatric patients.
Heble DE; McPherson C; Nelson MP; Hunstad DA
Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin dosing in obese pediatric patients.
Moffett BS; Kim S; Edwards MS
Clin Pediatr (Phila); 2011 May; 50(5):442-6. PubMed ID: 21282257
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
Aubron C; Corallo CE; Nunn MO; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Oct; 45(10):1193-8. PubMed ID: 21896920
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM
Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
